These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30482746)

  • 1. Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.
    Miller AM; Bahmanof M; Zehn D; Cohen EEW; Schoenberger SP
    Cancer Immunol Res; 2019 Jan; 7(1):40-49. PubMed ID: 30482746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Gröschel C; Sasse A; Monecke S; Röhrborn C; Elsner L; Didié M; Reupke V; Bunt G; Lichtman AH; Toischer K; Zimmermann WH; Hasenfuß G; Dressel R
    Front Immunol; 2018; 9():2665. PubMed ID: 30498501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
    Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
    Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity.
    Weinhold M; Sommermeyer D; Uckert W; Blankenstein T
    J Immunol; 2007 Oct; 179(8):5534-42. PubMed ID: 17911640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
    Tucker CG; Mitchell JS; Martinov T; Burbach BJ; Beura LK; Wilson JC; Dwyer AJ; Singh LM; Mescher MF; Fife BT
    J Immunol; 2020 Sep; 205(5):1449-1460. PubMed ID: 32737148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
    Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
    J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity.
    Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF
    Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice.
    Ahmed KA; Xie Y; Zhang X; Xiang J
    Cell Mol Immunol; 2008 Dec; 5(6):407-15. PubMed ID: 19118506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
    Liu Z; Lefrançois L
    J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
    Miyagawa F; Gutermuth J; Zhang H; Katz SI
    J Autoimmun; 2010 Nov; 35(3):192-8. PubMed ID: 20655706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.
    Liu W; Evanoff DP; Chen X; Luo Y
    J Immunol; 2007 Jan; 178(1):539-46. PubMed ID: 17182594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive class I-restricted exogenous presentation of self antigens in vivo.
    Kurts C; Heath WR; Carbone FR; Allison J; Miller JF; Kosaka H
    J Exp Med; 1996 Sep; 184(3):923-30. PubMed ID: 9064352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
    Goldberg J; Shrikant P; Mescher MF
    J Immunol; 2003 Jan; 170(1):228-35. PubMed ID: 12496404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.